BepotastineThird Party Manufacturing in India

Bepotastine works by acting as a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells. It inhibits eosinophil chemotaxis into inflamed tissues to help the body suppress acute allergic conjunctivitis symptoms like ocular pruritus. Unlike older systemic antihistamines, it provides rapid local relief with minimal systemic absorption. It is highly effective and well-tolerated for daily ocular allergy management.

Therapeutic Uses

• Allergic Conjunctivitis: Indicated for the temporary relief of ocular itching associated with seasonal and perennial allergic conjunctivitis.
• Ocular Inflammation: Used to alleviate secondary redness and irritation caused by environmental allergens.

Why Manufacturers Choose Bepotastine

Bepotastine third party manufacturing in India is seeing rapid growth due to the rising global prevalence of ocular allergies and the high consumer preference for fast-acting topical formulations. Celesta leverages strategic partnerships with premium facilities where partner facilities are WHO-GMP certified to ensure maximum product purity and long-term stability. Brands choose this molecule because it offers a premium competitive edge over first-generation ophthalmic antihistamines, making it a highly profitable addition to specialized ophthalmic product lines manufactured under strict WHO-GMP compliance.